youA US breast cancer vaccine has shown promising results in the first phase of testing. According to a study published in the scientific journal JAMA Oncology, the immunizer is safe for humans.
The investigation, conducted by scientists from Washington University of Medicine and the Fred Hutchinson Cancer Center, showed that the immunizer triggered the production of T cells, defense cells that are part of the immune system and whose function is to destroy molecules that threaten the body. . .
As such, the data from this study lends impetus to the investigation. However, the researchers warn that the complexity of the vaccine must be taken into account. Now two more test phases follow.